| Literature DB >> 27975081 |
Aziz Ari1, Kenan Buyukasik1, Cihad Tatar1, Ozgur Segmen1, Feyzullah Ersoz1, Soykan Arikan1, Feray Gunver2, Serkan Sari1.
Abstract
Background. The aim of this study is to discuss the laparoscopic approach and assess the immunohistochemical expression profiles of synaptophysin, Ki-67, and inhibin and patient outcomes in adrenal masses through a series of cases treated at our institution. Method. The study was conducted on 58 patients who were diagnosed with adrenal masses. All cases were operated on laparoscopically for adrenal masses. Results. Both inhibin and synaptophysin were found positive in 45 patients (77,6%). Ki-67 was negative in 11 patients, whereas it was found positive in 42 with a rate of 1%. The size of the masses ranged from 1 up to 9 cm (mean 4,3 ± 1,5). Urine hormone excretion was measured within normal ranges in 47 out of 58 patients (81%). Most of the diagnosed patients were harboring Cortical Adenoma (n: 38; 65,5%). All of the masses were successfully resected without complication except 3 patients. Because of complications of bleeding, the operation was converted to open surgery for 2 patients. Conclusion. Morbidity, mortality, and healing were comparable, regardless of tumor size, yet involvement in both laparoscopic and adrenal surgery was required. Our results suggested that laparoscopic adrenalectomy should replace open surgery as the standard treatment for most adrenal masses.Entities:
Year: 2016 PMID: 27975081 PMCID: PMC5128712 DOI: 10.1155/2016/9574391
Source DB: PubMed Journal: Surg Res Pract ISSN: 2356-6124
Demographics and tumor characteristics (n: 58).
| Mean age, mean (range) | 49,8 ± 11,3 (21–77) |
| Male/female, | 30/28 |
| BMI, median (range) | 27.8 kg/m2 (18,1–40) |
| Side (left/right), | 23/35 |
| Ki67 positivity, | 41 (70%) |
| Inhibin positivity, | 45 (77,5%) |
| Synaptophysin positivity, | 45 (77,5%) |
| Mean tumor size, mean (range) | 4,3 ± 1,5 cm (1–9) |
Postoperational outcomes of all operated cases.
| Operating time, median (range) | 80 min (55–190) |
| Estimated blood loss, median (range) | 150 mL (100–600) |
| Regular urine hormone, | 47 (81%) |
| Regular venous hormone, | 48 (82.7%) |
| Complications, | 3 (5.1%) |
| Major complications, | 2 (3.4%) |
| Mortality, | None |
Pathologic types of all excised adrenal masses.
| Tumor types |
| % |
|---|---|---|
| Cortical Adenoma | 38 | 65,5 |
| Pheochromocytoma | 9 | 15,5 |
| Adenocarcinoma Infiltration | 2 | 3,4 |
| Benign cystic formation | 2 | 3,4 |
| Mucinous adenocarcinoma | 2 | 3,4 |
| Myelolipoma | 2 | 3,4 |
| Adrenocortical | 1 | 1,7 |
| Adrenal lipoma | 1 | 1,7 |
| Suprarenal cyst | 1 | 1,7 |